News and Media Coverage

Clinical research in India is poised for an era of exponential growth, presenting a landscape rich with potential opportunities. As the global hub for pharmaceutical and biotech research, India stands at the cusp of transformative advancements in the clinical research … Continued

The landscape of Biopharmaceutical companies in India stands as a testament to the transformative power of innovation in medicine by the nation. These entities have redefined the norms of drug discovery and development, showcasing their prowess on a global stage … Continued

India has been a global centre for medicine in recent decades, and molecular research has played a critical role in this amazing success story. A key component of India’s pharmaceutical industry, molecules research is the process of finding and creating … Continued

India’s biotechnology industry has experienced a spectacular upsurge in the last several years, making it a global success story. The combination of biology and technology, or biotechnology, is a broad field with applications in everything from environmental protection to agriculture … Continued

A Covid-19 drug manufactured by Kerala-based company, PNB Vesper, has received nod by DCGI to conduct Phase 3 clinical trials. The company will be conducting a nationwide multi-centred clinical trial of the drug- PNB-001 (GPP-BALACOVIN), on Covid-19 patients who are … Continued

Kerala-based pharmaceutical organization PNB Vesper has received DCGI permission to conduct the final phase 3 clinical trials. After a detailed deliberation by the Subject Expert Committee (SEC) on the Phase 2 Clinical Trial results of PNB-001 (GPP-BALACOVIN), the company has … Continued

PNB Vesper, a leading Kerala-based life sciences company received permission from the DCGI and entering into the final phase 3 clinical trials. After a detailed deliberation by the Subject Expert Committee (SEC) on the phase 2 clinical trial results of … Continued

The Phase 3 trial will be conducted on a large patient population in 12 hospitals all over India. GPP- BALACOVIN is a novel and safe drug that possesses significant efficacy to save the hospitalised patients with oxygen support, from the … Continued

PNB Vesper has received permission from the Drugs Controller General of India (DCGI) to enter into the phase-III clinical trials of PNB 001/GPP-BALACOVIN, the company said in a statement. After a detailed deliberation by the Subject Expert Committee (SEC) on … Continued